"The U.S. Food and Drug Administration today approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p deletion and who have been treated with a least one pr"...
Cerubidine (daunorubicin) is contraindicated in patients who have shown a hypersensitivity to it.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/13/2008
Additional Cerubidine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.